134 related articles for article (PubMed ID: 9756413)
21. CD40-CD40L interactions provide "third-party" costimulation for T cell response against B7-1-transfected human breast tumor cells.
Pericle F; Epling-Burnette PK; Podack ER; Wei S; Djeu JY
J Leukoc Biol; 1997 Feb; 61(2):201-8. PubMed ID: 9021926
[TBL] [Abstract][Full Text] [Related]
22. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
Ito D; Ogasawara K; Iwabuchi K; Inuyama Y; Onoé K
J Immunol; 2000 Feb; 164(3):1230-5. PubMed ID: 10640735
[TBL] [Abstract][Full Text] [Related]
23. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression.
Kalinichenko VV; Mokyr MB; Graf LH; Cohen RL; Chambers DA
J Immunol; 1999 Sep; 163(5):2492-9. PubMed ID: 10452985
[TBL] [Abstract][Full Text] [Related]
24. Triggering of murine NK cells by CD40 and CD86 (B7-2).
Martín-Fontecha A; Assarsson E; Carbone E; Kärre K; Ljunggren HG
J Immunol; 1999 May; 162(10):5910-6. PubMed ID: 10229827
[TBL] [Abstract][Full Text] [Related]
25. Augmentation of the generation of cytotoxic T lymphocytes against syngeneic tumor cells by recombinant human tumor necrosis factor.
Nakano K; Okugawa K; Furuichi H; Matsui Y; Sohmura Y
Cell Immunol; 1989 Apr; 120(1):154-64. PubMed ID: 2649256
[TBL] [Abstract][Full Text] [Related]
26. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
[TBL] [Abstract][Full Text] [Related]
27. Importance of the B7-2 molecule for low dose melphalan-induced acquisition of tumor-eradicating immunity by mice bearing a large MOPC-315 tumor.
Mokyr MB; Kalinichenko TV; Gorelik L; Bluestone JA
J Immunol; 1998 Feb; 160(4):1866-74. PubMed ID: 9469448
[TBL] [Abstract][Full Text] [Related]
28. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.
Schoenberger SP; Toes RE; van der Voort EI; Offringa R; Melief CJ
Nature; 1998 Jun; 393(6684):480-3. PubMed ID: 9624005
[TBL] [Abstract][Full Text] [Related]
29. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
[TBL] [Abstract][Full Text] [Related]
31. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
[TBL] [Abstract][Full Text] [Related]
32. Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine.
Cusi MG; Del Vecchio MT; Terrosi C; Savellini GG; Di Genova G; La Placa M; Fallarino F; Moser C; Cardone C; Giorgi G; Francini G; Correale P
J Immunol; 2005 Jun; 174(11):7210-6. PubMed ID: 15905566
[TBL] [Abstract][Full Text] [Related]
33. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction.
Imaizumi K; Kawabe T; Ichiyama S; Kikutani H; Yagita H; Shimokata K; Hasegawa Y
Am J Physiol; 1999 Jul; 277(1):L49-57. PubMed ID: 10409230
[TBL] [Abstract][Full Text] [Related]
35. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL.
McAdam AJ; Gewurz BE; Farkash EA; Sharpe AH
J Immunol; 2000 Sep; 165(6):3088-93. PubMed ID: 10975820
[TBL] [Abstract][Full Text] [Related]
36. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
Harding FA; Allison JP
J Exp Med; 1993 Jun; 177(6):1791-6. PubMed ID: 7684435
[TBL] [Abstract][Full Text] [Related]
37. Interaction between B.7 and CD28 costimulatory molecules is essential for the activation of effector function mediating spontaneous tumour regression.
Rao KL; Varalakshmi C; Kumari AL; Khar A
Scand J Immunol; 1999 Jun; 49(6):633-40. PubMed ID: 10354375
[TBL] [Abstract][Full Text] [Related]
38. Thymic medullary epithelium and thymocyte self-tolerance require cooperation between CD28-CD80/86 and CD40-CD40L costimulatory pathways.
Williams JA; Zhang J; Jeon H; Nitta T; Ohigashi I; Klug D; Kruhlak MJ; Choudhury B; Sharrow SO; Granger L; Adams A; Eckhaus MA; Jenkinson SR; Richie ER; Gress RE; Takahama Y; Hodes RJ
J Immunol; 2014 Jan; 192(2):630-40. PubMed ID: 24337745
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response.
Popma SH; Krasinskas AM; Kreisel D; Szeto W; McLean AD; Moore JS; Rosengard BR
Transplant Proc; 2001; 33(1-2):767-9. PubMed ID: 11267061
[No Abstract] [Full Text] [Related]
40. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
Prell RA; Kerkvliet NI
J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]